Europe
Processes and policies governing the reuse and recycling of electronic products need to be standardized worldwide to stem and reverse the growing problem of illegal and harmful e-waste processing practices in developing countries, according to experts behind the world's first international e-waste academy.
The first of three images of ESO's GigaGalaxy Zoom project -- a new magnificent 800-million-pixel panorama of the entire sky as seen from ESO's observing sites in Chile -- has just been released online. The project allows stargazers to explore and experience the Universe as it is seen with the unaided eye from the darkest and best viewing locations in the world.
ROCHESTER, Minn. -- A Mayo Clinic study has found that two genes in mice were associated with good central nervous system repair in multiple sclerosis (MS). These findings give researchers new hope for developing more effective therapies for patients with MS and for predicting MS patients' outcomes.
CAMBRIDGE, MA -- Sept. 11, 2009 -- Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon beta-1a IM) reported significantly fewer injection site reactions (ISRs) compared to patients on Betaferon® (interferon beta-1b), Copaxone® (glatiramer Acetate) or Rebif ® (interferon beta-1a).
Lisbon, Portugal 11 September, 2009 -- The first results of the first European survey of cancer patients? experience of breakthrough pain were presented today at the 6th congress of the European Federation of Chapters of the International Association for the Study of Pain (EFIC).
Lisbon, Portugal 11 September, 2009 -- New data presented today further demonstrate the efficacy of Instanyl in management of breakthrough cancer pain.
Sharing the fruits of research in the biomedical sciences is critical for the advance of knowledge, yet with the advent of large-scale data gathering following the completion of the genome projects this is becoming harder to facilitate and more difficult to monitor, as reported in Nature today.
A large international research team has decoded the genome of the notorious organism that triggered the Irish potato famine in the mid-19th century and now threatens this season's tomato and potato crops across much of the US.
As part of the development process for ESA's Sentinel-3 Earth observation mission, remote-sensing experts carried out an extensive experiment campaign across southern Europe this summer. The results provide valuable insight into the imagery the mission will deliver after it is launched in 2013.
Tobacco use is prohibited in hospitals in many European countries, although levels of compliance with this regulation differ. A study carried out by researchers from the Catalan Institute of Oncology (ICO) has shown for the first time that exposure to environmental tobacco smoke in European hospitals is "low", and "without any notable differences" between them.
This is the conclusion of a study which has analyzed the persecution of birds as a result of hunting in Spain over 14 years. The decrease in this activity and the fall in the number of animals admitted to recovery centres (by a yearly 10%) are the reasons why the "war", in the sense of direct persecution, is drawing to a close in southern Europe.
VERONA, MS -- A common weed called American mayapple may soon offer an alternative to an Asian cousin that's been harvested almost to extinction because of its anti-cancer properties. The near-extinct Asian plant, Podophyllyum emodi, produces podophyllotoxin, a compound used in manufacturing etoposide, the active ingredient in a drug used for treating lung and testicular cancer.
Analysis of ancient DNA from skeletons suggests that Europe's first farmers were not the descendants of the people who settled the area after the retreat of the ice sheets.
Patients who had a cardiac resynchronization device combined with a defibrillator (CRT-D) implanted had a 34 percent reduction in their risk of death or heart failure when compared to patients receiving only an implanted cardiac defibrillator (ICD), according to a landmark study published online today in the New England Journal of Medicine and presented today at the European Society of C
Barcelona, Spain, 1 September: Asymptomatic or mildly symptomatic cardiac patients randomised to an implanted cardiac resynchronisation device with defibrillator (CRT-D) have a 34% lower risk of heart failure or death than those receiving a standard implanted cardioverter defibrillator (ICD-only) (HR 0.66, p=0.001), according to results from the MADIT-CRT (Multicenter Automatic Defibrillator Im
